Khiron Life Sciences Sees Exponential Growth in the Following Year

- August 1st, 2018

Khiron Life Sciences’ (TSXV:KHRN) recently appointed president, Chris Naprawa, was featured in an interview with Let’s Toke Business.

Khiron Life Sciences’ (TSXV:KHRN) recently appointed president, Chris Naprawa, was featured in an interview with Let’s Toke Business.

In the interview, Naprawa discussed his background in sales, capital markets and his experience as an entrepreneur. He also outlined his plans for increasing Khiron’s market cap through establishing relationships with institutional investors and shareholders over the next year.

“Khiron with a market capitalization of around $50 million sells at a deep discount to some of our direct competitors. Given the people we have and the headway we are making, I think we should trade at a premium,” said Naprawa.

Naprawa also discussed the recent additions to the Khiron executive team. He believes that the executive team at Khiron is a strong one and that’s the reason why former Mexican President Vicente Fox Quesada recently joined the team at Khiron.

“Mr. Fox is passionate about the space. He knows just about anyone who is anyone in Mexico and he can open doors and make introductions. He is a center of influence who also brings a certain amount of celebrity and cachet. He is going to be an important asset for us,” said Newprawa.

To read the full article, click here.

Click here to connect with Khiron Life Sciences (TSXV:KHRN) for an Investor Presentation.

Get the latest Cannabis Investing stock information

Leave a Reply